Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 5
Submit an article Journal homepage
111
Views
10
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Targeting the follicular lymphoma microenvironment through blockade of TNFα with etanercept

Jonathan Friedberg James P. Wilmot Cancer Centre, University of Rochester, Rochester, NY, USA
,
Eric Jacobsen Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
,
Donna Neuberg Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
,
Jeffrey Kutok Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
,
Olivier Munoz Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
,
Vassiliki Boussiotis Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
,
Hazel Reynolds Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
,
David Fisher Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
,
Agnieszka Szot Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
,
Annick Van Den Abbeele Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
&
Arnold Freedman Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USACorrespondence[email protected]
 show all
Pages 902-909 | Received 31 Oct 2007, Accepted 26 Jan 2008, Published online: 01 Jul 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Matthew C. Cheung & Kevin R. Imrie. (2008) Targeting the follicular lymphoma microenvironment – Ready for prime-time?. Leukemia & Lymphoma 49:5, pages 837-838.
Read now

Articles from other publishers (9)

Guanjun Dong, Ming You, Hongye Fan, Jianjian Ji, Liang Ding, Pengfei Li & Yayi Hou. (2015) 17β-estradiol contributes to the accumulation of myeloid-derived suppressor cells in blood by promoting TNF-α secretion. Acta Biochimica et Biophysica Sinica 47:8, pages 620-629.
Crossref
Michele Hooper, Deborah Wenkert, Bojena Bitman, Virgil C Dias & Yessenia Bartley. (2013) Malignancies in children and young adults on etanercept: summary of cases from clinical trials and post marketing reports. Pediatric Rheumatology 11:1.
Crossref
Moshe Sade-Feldman, Julia Kanterman, Eliran Ish-Shalom, Mazal Elnekave, Elad Horwitz & Michal Baniyash. (2013) Tumor Necrosis Factor-α Blocks Differentiation and Enhances Suppressive Activity of Immature Myeloid Cells during Chronic Inflammation. Immunity 38:3, pages 541-554.
Crossref
Daofeng Liu, Liping Song, Jie Wei, Amy N. Courtney, Xiuhua Gao, Ekaterina Marinova, Linjie Guo, Andras Heczey, Shahab Asgharzadeh, Eugene Kim, Gianpietro Dotti & Leonid S. Metelitsa. (2012) IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity. Journal of Clinical Investigation 122:6, pages 2221-2233.
Crossref
Loreto Carmona, Lydia Abasolo, Miguel A. Descalzo, Beatriz Pérez-Zafrilla, Agustí Sellas, Francisco de Abajo & Juan J. Gomez-Reino. (2011) Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists. Seminars in Arthritis and Rheumatism 41:1, pages 71-80.
Crossref
A. García-Rabasco, J.L. Sánchez-Carazo & A. Esteve. (2010) Etanercept y neoplasias. Actas Dermo-Sifiliográficas 101, pages 88-96.
Crossref
Loreto Carmona. (2010) Terapias anti-TNF y neoplasias. Reumatología Clínica 6:2, pages 102-105.
Crossref
Loreto Carmona. (2010) Anti-TNF therapy and cancer. Reumatología Clínica (English Edition) 6:2, pages 102-105.
Crossref
Jonathan W. Friedberg, Jennifer L. Kelly, Donna Neuberg, Derick R. Peterson, Jeffery L. Kutok, Rabih Salloum, Thomas Brenn, David C. Fisher, Elizabeth Ronan, Virginia Dalton, Lynn Rich, Diana Marquis, Paul Sims, Paul G. Rothberg, Jane Liesveld, Richard I. Fisher, Robert Coffman, Tim Mosmann & Arnold S. Freedman. (2009) Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma. British Journal of Haematology 146:3, pages 282-291.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.